Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy

Fig. 3

Changes of CAML sizes in non-progressing or progressing patients before, during and after induction of CRT. Average trends in the largest CAML size were visualized by averaging all patients that did not progress within 24 months (a, b) or all patients that progressed within 24 months (c, d) black dotted lines. a, b 70% of patients that did not progress within 2 years had an increase in macrophage engorgement during CRT, with a decrease in engorgement after treatment completion. c, d 60% of patients that progressed within 2 years had a gradual increase in macrophage engorgement at every time point during CRT with an overall increase in after treatment completion. Patients with a single time, i.e.no sequential data available, are indicated by open circles

Back to article page